Search

Your search keyword '"Ntaios, George"' showing total 1,475 results

Search Constraints

Start Over You searched for: Author "Ntaios, George" Remove constraint Author: "Ntaios, George"
1,475 results on '"Ntaios, George"'

Search Results

52. Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19

53. Inpatient Cost of Stroke Care in Greece: Preliminary Results of the Web-Based “SUN4P” Registry

54. Assessing Staff’s and Stroke Patients’ Experiences in 8 Hospitals in Greece: Results from a Prospective Multi-Center Study (“SUN4Patients”)

55. Stroke Units Necessity for Patients, Web-Based “SUN4P” Registry: Descriptive Characteristics of the Population

59. Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment

60. The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019

61. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

62. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

63. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

64. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

65. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

67. Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort Studies.

68. Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.

70. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy

78. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial

80. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

82. Idarucizumab in dabigatran-treated patients with acute stroke: a review and clinical update.

83. Sex differences in acute stroke metrics and outcome dependent on COVID status.

84. Magnetic resonance imaging for diagnostic workup of embolic stroke of undetermined source: A systematic review.

85. Beyond antithrombotics: recent advances in pharmacological risk factor management for secondary stroke prevention.

86. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study

87. Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis

90. Natriuretic Peptides Improve Classification of People at Low Risk of Atrial Fibrillation after Stroke

93. The Cost and the Value of Stroke Care in Greece: Results from the SUN4P Study

95. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial

98. Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention

100. Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke

Catalog

Books, media, physical & digital resources